Skip to Content


In the US, Jardiance (empagliflozin systemic) is a member of the drug class SGLT-2 inhibitors and is used to treat Cardiovascular Risk Reduction and Diabetes - Type 2.

US matches:

UK matches:

Ingredient matches for Jardiance


Empagliflozin is reported as an ingredient of Jardiance in the following countries:

  • Austria
  • Bosnia & Herzegowina
  • Croatia (Hrvatska)
  • Denmark
  • Finland
  • Germany
  • Ireland
  • Poland
  • Singapore
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.